Future Science Group
FON-2021-1367.docx (19.65 kB)

fon-2021-1367 – First-line gemcitabine plus nab-paclitaxel versus FOLFIRINOX for metastatic pancreatic cancer in a real-world population

Download (19.65 kB)
posted on 2022-05-19, 08:05 authored by Alycia Hatashima, Matthew J Arango, Joshua Reardon, Tracelyn Freeman, Terence Williams, Eric M McLaughlin, Laith Abushahin


Table S1 Hazard Ratios with and without Inverse Probability Weights


Table S2 Multivariate Analysis: Prognostic Factors for Overall Survival


Ohio State University Center for Clinical and Translational Science grant support (National Center for Advancing Translational Sciences, Grant UL1TR001070)